Share Price and Basic Stock Data
Last Updated: December 18, 2025, 11:13 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
CNI Research Ltd operates in the finance and investment sector, with a market capitalization of ₹107 Cr. The company’s recent revenue trajectory has been somewhat erratic. For instance, sales peaked at ₹3.40 Cr in September 2022 but dropped to ₹0.93 Cr by March 2023. However, the latest quarterly results show a recovery, with revenues rising to ₹2.56 Cr in September 2023, indicating that the company is attempting to stabilize its income stream. Year-on-year, the sales for the fiscal year ending March 2024 are reported at ₹10.58 Cr, a modest increase compared to ₹9.59 Cr in the previous year. This suggests that while CNI Research is navigating challenges, it is also making incremental progress in its revenue generation efforts. Investors should note that the company is heavily reliant on market conditions, which can lead to volatility in sales figures.
Profitability and Efficiency Metrics
Profitability remains a concern for CNI Research, with a reported net profit of -₹4.13 Cr for the latest fiscal year. This negative figure is symptomatic of the broader challenges the company faces. The operating profit margin (OPM) has fluctuated significantly, standing at 10.71% recently, yet it has seen periods of negative margins, particularly in the last quarter of FY 2025, where it plummeted to -88.74%. Such volatility raises questions about the company’s cost management and operational efficiency. The return on equity (ROE) and return on capital employed (ROCE) both reported at 25.3%, which appear strong, suggest that when the company does generate profits, it does so with respectable efficiency. However, the negative net profit indicates that these ratios may not fully reflect the company’s ongoing operational struggles.
Balance Sheet Strength and Financial Ratios
CNI Research’s balance sheet shows a conservative approach to financing, with no reported borrowings, which places it in a strong liquidity position. The company’s reserves stood at ₹4.76 Cr, a sign of a solid foundation for future growth despite recent losses. The price-to-book value ratio at 3.04x indicates that investors are currently valuing the company at a premium compared to its book value, which could signal confidence in its long-term viability. However, the cash conversion cycle remains at 0.00 days, suggesting that the company is operating efficiently in terms of cash flow management, yet this could also hint at issues in revenue generation. The current ratio is extraordinarily high at 108.57, indicating that the company has ample liquidity to cover its short-term liabilities, which is a positive sign for investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern reveals a stable ownership structure, with promoters holding 37.11% of shares, while public shareholders account for a substantial 62.81%. This distribution suggests a wide base of retail investor participation and a degree of confidence from the promoters in the company’s future. Interestingly, foreign institutional investors (FIIs) have only a minimal presence at 0.09%, which may imply that the stock is not currently considered attractive to larger institutional investors. The increase in the number of shareholders from 13,103 in December 2022 to 18,903 in September 2025 indicates growing interest from the retail segment, which could be a positive indicator of investor sentiment. However, the lack of institutional backing raises questions about the stock’s perceived stability and growth potential.
Outlook, Risks, and Final Insight
Looking ahead, CNI Research Ltd faces a mixed bag of opportunities and challenges. On one hand, the company’s strong liquidity position and absence of debt provide a buffer against market fluctuations, which is a significant advantage in the volatile finance sector. However, the erratic revenue trends and negative profitability figures could deter potential investors. The company’s operational efficiency, as reflected in its ROE and ROCE, offers a glimmer of hope, yet the stark reality of negative net profits cannot be ignored. Investors should remain cautious, keeping in mind that while CNI Research has the potential to rebound, it must first stabilize its revenue streams and return to consistent profitability. The reliance on retail investment may also mean that the stock is susceptible to market sentiment swings. Overall, a careful evaluation of these factors is essential for any investor considering exposure to CNI Research Ltd.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 11.9 Cr. | 40.5 | 67.7/36.4 | 47.5 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,381 Cr. | 300 | 484/280 | 15.3 | 111 | 0.33 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 33.0 Cr. | 0.47 | 2.02/0.45 | 4.58 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 5.45 Cr. | 11.0 | 12.6/8.25 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 20.8 Cr. | 40.6 | 72.0/40.6 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 7,228.32 Cr | 1,373.88 | 82.37 | 3,844.37 | 0.36% | 21.71% | 14.20% | 7.22 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.88 | 3.40 | 3.04 | 0.93 | 2.43 | 2.56 | 1.86 | 2.78 | 4.00 | 0.33 | 0.05 | 0.03 | 0.28 |
| Expenses | 1.89 | 3.29 | 2.95 | 0.97 | 2.47 | 2.50 | 1.78 | 2.82 | 3.96 | 3.32 | 0.95 | 0.14 | 0.25 |
| Operating Profit | -0.01 | 0.11 | 0.09 | -0.04 | -0.04 | 0.06 | 0.08 | -0.04 | 0.04 | -2.99 | -0.90 | -0.11 | 0.03 |
| OPM % | -0.53% | 3.24% | 2.96% | -4.30% | -1.65% | 2.34% | 4.30% | -1.44% | 1.00% | -906.06% | -1,800.00% | -366.67% | 10.71% |
| Other Income | 0.22 | 0.12 | 0.47 | -1.82 | 0.66 | 0.09 | -0.28 | 0.32 | 0.18 | -0.17 | -0.00 | 0.01 | -0.00 |
| Interest | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Depreciation | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Profit before tax | 0.21 | 0.23 | 0.56 | -1.86 | 0.62 | 0.15 | -0.20 | 0.28 | 0.22 | -3.16 | -0.90 | -0.10 | 0.03 |
| Tax % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 3.57% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
| Net Profit | 0.21 | 0.23 | 0.56 | -1.86 | 0.62 | 0.15 | -0.20 | 0.27 | 0.22 | -3.16 | -0.90 | -0.10 | 0.03 |
| EPS in Rs | 0.02 | 0.02 | 0.05 | -0.16 | 0.05 | 0.01 | -0.02 | 0.02 | 0.02 | -0.28 | -0.08 | -0.01 | 0.00 |
Last Updated: August 19, 2025, 9:00 pm
Below is a detailed analysis of the quarterly data for CNI Research Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.28 Cr.. The value appears strong and on an upward trend. It has increased from 0.03 Cr. (Mar 2025) to 0.28 Cr., marking an increase of 0.25 Cr..
- For Expenses, as of Jun 2025, the value is 0.25 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.14 Cr. (Mar 2025) to 0.25 Cr., marking an increase of 0.11 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.03 Cr.. The value appears strong and on an upward trend. It has increased from -0.11 Cr. (Mar 2025) to 0.03 Cr., marking an increase of 0.14 Cr..
- For OPM %, as of Jun 2025, the value is 10.71%. The value appears strong and on an upward trend. It has increased from -366.67% (Mar 2025) to 10.71%, marking an increase of 377.38%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.01 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.01 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.03 Cr.. The value appears strong and on an upward trend. It has increased from -0.10 Cr. (Mar 2025) to 0.03 Cr., marking an increase of 0.13 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is 0.03 Cr.. The value appears strong and on an upward trend. It has increased from -0.10 Cr. (Mar 2025) to 0.03 Cr., marking an increase of 0.13 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.00. The value appears strong and on an upward trend. It has increased from -0.01 (Mar 2025) to 0.00, marking an increase of 0.01.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:56 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.89 | 22.66 | 48.53 | 1.80 | 4.40 | 4.03 | 2.33 | -2.31 | 7.86 | 9.59 | 10.58 | 4.44 | 0.38 |
| Expenses | 3.19 | 23.93 | 48.25 | 2.18 | 4.51 | 4.53 | 2.58 | 1.30 | 6.14 | 10.45 | 9.73 | 8.38 | 1.41 |
| Operating Profit | -0.30 | -1.27 | 0.28 | -0.38 | -0.11 | -0.50 | -0.25 | -3.61 | 1.72 | -0.86 | 0.85 | -3.94 | -1.03 |
| OPM % | -10.38% | -5.60% | 0.58% | -21.11% | -2.50% | -12.41% | -10.73% | -10.17% | 21.88% | -8.97% | 8.03% | -88.74% | -271.05% |
| Other Income | 0.34 | 2.54 | -0.71 | 0.52 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.01 | 1.27 | -0.43 | 0.14 | 0.11 | -0.50 | -0.25 | -3.61 | 1.72 | -0.86 | 0.85 | -3.94 | -1.02 |
| Tax % | -1,600.00% | 20.47% | 0.00% | 14.29% | 18.18% | 0.00% | 0.00% | 0.00% | 1.16% | 0.00% | 1.18% | 0.00% | |
| Net Profit | 0.17 | 1.01 | -0.43 | 0.11 | 0.09 | -0.50 | -0.25 | -3.61 | 1.70 | -0.86 | 0.84 | -3.94 | -1.02 |
| EPS in Rs | 0.03 | 0.09 | -0.04 | 0.01 | 0.01 | -0.04 | -0.02 | -0.31 | 0.15 | -0.07 | 0.07 | -0.34 | -0.09 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 494.12% | -142.57% | 125.58% | -18.18% | -655.56% | 50.00% | -1344.00% | 147.09% | -150.59% | 197.67% | -569.05% |
| Change in YoY Net Profit Growth (%) | 0.00% | -636.69% | 268.16% | -143.76% | -637.37% | 705.56% | -1394.00% | 1491.09% | -297.68% | 348.26% | -766.72% |
CNI Research Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -15% |
| 5 Years: | 14% |
| 3 Years: | -17% |
| TTM: | -94% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -1039% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 50% |
| 3 Years: | 49% |
| 1 Year: | -1% |
| Return on Equity | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | -11% |
| 3 Years: | -10% |
| Last Year: | -25% |
Last Updated: September 5, 2025, 3:01 pm
Balance Sheet
Last Updated: December 4, 2025, 2:39 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.48 | 10.94 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 |
| Reserves | 5.61 | 11.35 | 11.19 | 6.48 | 4.72 | 0.24 | -5.93 | -3.67 | 0.97 | -2.02 | 3.43 | 4.77 | 4.76 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.15 | 0.58 | 0.28 | 0.04 | 0.03 | 0.01 | 0.10 | 0.07 | 0.05 | 0.02 | 0.02 | 0.05 | 0.03 |
| Total Liabilities | 12.24 | 22.87 | 22.95 | 18.00 | 16.23 | 11.73 | 5.65 | 7.88 | 12.50 | 9.48 | 14.93 | 16.30 | 16.27 |
| Fixed Assets | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 10.55 | 17.33 | 22.40 | 17.53 | 14.47 | 11.42 | 5.32 | 7.51 | 11.09 | 8.65 | 12.44 | 12.81 | 12.81 |
| Other Assets | 1.67 | 5.53 | 0.54 | 0.46 | 1.76 | 0.31 | 0.33 | 0.37 | 1.41 | 0.83 | 2.49 | 3.49 | 3.46 |
| Total Assets | 12.24 | 22.87 | 22.95 | 18.00 | 16.23 | 11.73 | 5.65 | 7.88 | 12.50 | 9.48 | 14.93 | 16.30 | 16.27 |
Below is a detailed analysis of the balance sheet data for CNI Research Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 11.48 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.48 Cr..
- For Reserves, as of Sep 2025, the value is 4.76 Cr.. The value appears to be declining and may need further review. It has decreased from 4.77 Cr. (Mar 2025) to 4.76 Cr., marking a decrease of 0.01 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 0.03 Cr.. The value appears to be improving (decreasing). It has decreased from 0.05 Cr. (Mar 2025) to 0.03 Cr., marking a decrease of 0.02 Cr..
- For Total Liabilities, as of Sep 2025, the value is 16.27 Cr.. The value appears to be improving (decreasing). It has decreased from 16.30 Cr. (Mar 2025) to 16.27 Cr., marking a decrease of 0.03 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 12.81 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.81 Cr..
- For Other Assets, as of Sep 2025, the value is 3.46 Cr.. The value appears to be declining and may need further review. It has decreased from 3.49 Cr. (Mar 2025) to 3.46 Cr., marking a decrease of 0.03 Cr..
- For Total Assets, as of Sep 2025, the value is 16.27 Cr.. The value appears to be declining and may need further review. It has decreased from 16.30 Cr. (Mar 2025) to 16.27 Cr., marking a decrease of 0.03 Cr..
Notably, the Reserves (4.76 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.30 | -1.27 | 0.28 | -0.38 | -0.11 | -0.50 | -0.25 | -3.61 | 1.72 | -0.86 | 0.85 | -3.94 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 1.26 | 13.85 | 0.23 | 6.08 | 128.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 1.26 | 13.85 | 0.23 | 6.08 | 128.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Days | 190.71 | 8.54 | 0.08 | -2.03 | 126.09 | -0.91 | -15.67 | -11.06 | -1.86 | -0.38 | -0.34 | 268.00 |
| ROCE % | -0.83% | 1.11% | 1.96% | -0.54% | -0.64% | -3.58% | -2.90% | -54.04% | 16.98% | -7.85% | 6.98% | -25.29% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 0.07 | -0.07 | 0.15 | -0.31 | -0.02 |
| Diluted EPS (Rs.) | 0.07 | -0.07 | 0.15 | -0.31 | -0.02 |
| Cash EPS (Rs.) | 0.07 | -0.07 | 0.14 | -0.31 | -0.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.30 | 0.82 | 1.08 | 0.68 | 0.48 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.30 | 0.82 | 1.08 | 0.68 | 0.48 |
| Revenue From Operations / Share (Rs.) | 0.91 | 0.80 | 0.55 | 0.10 | 0.21 |
| PBDIT / Share (Rs.) | 0.07 | -0.07 | 0.14 | -0.31 | -0.02 |
| PBIT / Share (Rs.) | 0.07 | -0.07 | 0.14 | -0.31 | -0.02 |
| PBT / Share (Rs.) | 0.07 | -0.07 | 0.14 | -0.31 | -0.02 |
| Net Profit / Share (Rs.) | 0.07 | -0.07 | 0.14 | -0.31 | -0.02 |
| PBDIT Margin (%) | 8.12 | -9.26 | 26.98 | -304.76 | -9.97 |
| PBIT Margin (%) | 8.12 | -9.26 | 26.98 | -304.76 | -10.01 |
| PBT Margin (%) | 8.12 | -9.26 | 26.98 | -304.76 | -10.01 |
| Net Profit Margin (%) | 7.98 | -9.26 | 26.68 | -304.82 | -9.94 |
| Return on Networth / Equity (%) | 5.59 | -9.05 | 13.66 | -46.21 | -4.44 |
| Return on Capital Employeed (%) | 5.69 | -9.05 | 13.81 | -46.20 | -4.47 |
| Return On Assets (%) | 5.59 | -9.04 | 13.61 | -45.81 | -4.36 |
| Asset Turnover Ratio (%) | 0.85 | 0.84 | 0.62 | 0.17 | 0.28 |
| Current Ratio (X) | 108.57 | 47.93 | 30.97 | 5.13 | 3.13 |
| Quick Ratio (X) | 108.57 | 47.93 | 30.97 | 5.13 | 3.13 |
| Enterprise Value (Cr.) | 42.86 | 19.74 | 23.39 | 19.28 | 19.90 |
| EV / Net Operating Revenue (X) | 4.10 | 2.13 | 3.67 | 16.29 | 8.03 |
| EV / EBITDA (X) | 50.43 | -23.04 | 13.60 | -5.35 | -80.47 |
| MarketCap / Net Operating Revenue (X) | 4.34 | 2.22 | 3.89 | 16.58 | 8.15 |
| Price / BV (X) | 3.04 | 2.17 | 1.99 | 2.51 | 3.64 |
| Price / Net Operating Revenue (X) | 4.34 | 2.22 | 3.89 | 16.59 | 8.15 |
| EarningsYield | 0.01 | -0.04 | 0.06 | -0.18 | -0.01 |
After reviewing the key financial ratios for CNI Research Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 5. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For Diluted EPS (Rs.), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 5. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For Cash EPS (Rs.), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 3. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1.30. It has increased from 0.82 (Mar 23) to 1.30, marking an increase of 0.48.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1.30. It has increased from 0.82 (Mar 23) to 1.30, marking an increase of 0.48.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 0.91. It has increased from 0.80 (Mar 23) to 0.91, marking an increase of 0.11.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 2. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For PBIT / Share (Rs.), as of Mar 24, the value is 0.07. This value is within the healthy range. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For PBT / Share (Rs.), as of Mar 24, the value is 0.07. This value is within the healthy range. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 2. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For PBDIT Margin (%), as of Mar 24, the value is 8.12. This value is below the healthy minimum of 10. It has increased from -9.26 (Mar 23) to 8.12, marking an increase of 17.38.
- For PBIT Margin (%), as of Mar 24, the value is 8.12. This value is below the healthy minimum of 10. It has increased from -9.26 (Mar 23) to 8.12, marking an increase of 17.38.
- For PBT Margin (%), as of Mar 24, the value is 8.12. This value is below the healthy minimum of 10. It has increased from -9.26 (Mar 23) to 8.12, marking an increase of 17.38.
- For Net Profit Margin (%), as of Mar 24, the value is 7.98. This value is within the healthy range. It has increased from -9.26 (Mar 23) to 7.98, marking an increase of 17.24.
- For Return on Networth / Equity (%), as of Mar 24, the value is 5.59. This value is below the healthy minimum of 15. It has increased from -9.05 (Mar 23) to 5.59, marking an increase of 14.64.
- For Return on Capital Employeed (%), as of Mar 24, the value is 5.69. This value is below the healthy minimum of 10. It has increased from -9.05 (Mar 23) to 5.69, marking an increase of 14.74.
- For Return On Assets (%), as of Mar 24, the value is 5.59. This value is within the healthy range. It has increased from -9.04 (Mar 23) to 5.59, marking an increase of 14.63.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.85. It has increased from 0.84 (Mar 23) to 0.85, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 24, the value is 108.57. This value exceeds the healthy maximum of 3. It has increased from 47.93 (Mar 23) to 108.57, marking an increase of 60.64.
- For Quick Ratio (X), as of Mar 24, the value is 108.57. This value exceeds the healthy maximum of 2. It has increased from 47.93 (Mar 23) to 108.57, marking an increase of 60.64.
- For Enterprise Value (Cr.), as of Mar 24, the value is 42.86. It has increased from 19.74 (Mar 23) to 42.86, marking an increase of 23.12.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 4.10. This value exceeds the healthy maximum of 3. It has increased from 2.13 (Mar 23) to 4.10, marking an increase of 1.97.
- For EV / EBITDA (X), as of Mar 24, the value is 50.43. This value exceeds the healthy maximum of 15. It has increased from -23.04 (Mar 23) to 50.43, marking an increase of 73.47.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.34. This value exceeds the healthy maximum of 3. It has increased from 2.22 (Mar 23) to 4.34, marking an increase of 2.12.
- For Price / BV (X), as of Mar 24, the value is 3.04. This value exceeds the healthy maximum of 3. It has increased from 2.17 (Mar 23) to 3.04, marking an increase of 0.87.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.34. This value exceeds the healthy maximum of 3. It has increased from 2.22 (Mar 23) to 4.34, marking an increase of 2.12.
- For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.04 (Mar 23) to 0.01, marking an increase of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CNI Research Ltd:
- Net Profit Margin: 7.98%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 5.69% (Industry Average ROCE: 21.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.59% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 108.57
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 82.37)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.98%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | A/120, Gokul Arcade, Sahar Road, Mumbai Maharashtra 400057 | chamatcar@chamatcar.com www.cniresearchltd.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Kishor P Ostwal | Managing Director |
| Mrs. Sangita Ostwal | Non Exe.Non Ind.Director |
| Mr. Mayur Shantilal Doshi | Ind. Non-Executive Director |
| Mr. Arun Kumar S Jain | Ind. Non-Executive Director |
| Mr. Ramkripal Prashant Verma | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of CNI Research Ltd?
CNI Research Ltd's intrinsic value (as of 18 December 2025) is 4.37 which is 54.86% lower the current market price of 9.68, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 111 Cr. market cap, FY2025-2026 high/low of 16.3/7.03, reserves of ₹4.76 Cr, and liabilities of 16.27 Cr.
What is the Market Cap of CNI Research Ltd?
The Market Cap of CNI Research Ltd is 111 Cr..
What is the current Stock Price of CNI Research Ltd as on 18 December 2025?
The current stock price of CNI Research Ltd as on 18 December 2025 is 9.68.
What is the High / Low of CNI Research Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of CNI Research Ltd stocks is 16.3/7.03.
What is the Stock P/E of CNI Research Ltd?
The Stock P/E of CNI Research Ltd is .
What is the Book Value of CNI Research Ltd?
The Book Value of CNI Research Ltd is 1.41.
What is the Dividend Yield of CNI Research Ltd?
The Dividend Yield of CNI Research Ltd is 0.00 %.
What is the ROCE of CNI Research Ltd?
The ROCE of CNI Research Ltd is 25.3 %.
What is the ROE of CNI Research Ltd?
The ROE of CNI Research Ltd is 25.3 %.
What is the Face Value of CNI Research Ltd?
The Face Value of CNI Research Ltd is 1.00.